This page is for patients who have had cataract surgery and are experiencing gradual blurring of vision months to years later, and who want to understand whether PCO is the cause and what YAG laser involves.
PCO Is Not a Complication, It Is a Predictable Change
YAG capsulotomy achieves visual improvement in approximately 98-99% of cases, typically within hours of the procedure. After cataract surgery, the natural lens is removed but its outer shell, the capsular bag, is left in place to support the IOL. Residual lens epithelial cells on the inner surface of the posterior capsule can proliferate over months to years, gradually opacifying the membrane behind the IOL. This is posterior capsule opacification. It is not a surgical error, not a recurrence of cataract, and not a sign that the IOL is failing. It is a predictable biological response that occurs in approximately 20-30% of patients within two to five years of surgery.
The good news is that PCO is treated definitively in a five-minute outpatient procedure with an almost 100% success rate and visual improvement typically within hours.
Symptoms and Diagnosis
PCO produces progressive blur, glare, and halos that develop gradually over months. Patients often describe it as their cataract “coming back”, the visual experience is similar to early cataract, though the mechanism is entirely different. The diagnosis is immediate at slit lamp examination: the posterior capsule opacity is visible as a hazy membrane behind the IOL, often with a characteristic wrinkled or pearl-like appearance.
YAG Laser Capsulotomy: The Treatment
YAG laser capsulotomy uses a focused laser pulse to create a small opening in the posterior capsule, clearing the visual axis. The procedure takes five minutes, requires no incision, and is performed at the slit lamp under topical anaesthetic drops. Patients notice improved clarity typically within hours of the procedure.
Published success rate: approximately 98-99% of patients achieve improved visual acuity. There is no limit to when PCO can be treated, it can be addressed months or years after it develops. The IOL itself is not touched.
Risks of YAG Capsulotomy
YAG capsulotomy is one of the safest procedures in ophthalmology. The main risks are a transient rise in intraocular pressure (managed with a single drop of IOP-lowering medication at the time of treatment), rare IOL damage if the energy is imprecisely targeted, and a small increase in retinal detachment risk in high myopes (approximately 0.1-0.5% over subsequent years). The procedure is performed at Harley Street by Mr Mfazo Hove at Blue Fin Vision®.
Clinical Perspective
At Blue Fin Vision®, PCO is discussed as a named secondary intervention at every cataract and RLE consultation. Patients are told the IOL will not be touched, the treatment is five minutes, visual improvement is rapid. This is the information that prevents patients from presenting two years post-surgery convinced their operation has gone wrong. In our 2024-2025 post-operative cohort, PCO requiring YAG capsulotomy was identified in approximately 8% of patients at twenty-four-month review, consistent with published rates for hydrophobic acrylic IOL platforms.
Clinical Takeaway
PCO is a predictable biological change, not a complication. It affects approximately 20-30% of patients within two to five years. YAG laser capsulotomy resolves it in five minutes with approximately 98-99% success. At Blue Fin Vision®, YAG is performed at Harley Street by Mr Mfazo Hove. If your vision has gradually blurred months or years after cataract surgery, book a slit lamp review, PCO is the most likely cause and the solution is quick.
References
- Apple DJ, Peng Q, Visessook N, Werner L, Pandey SK, Escobar-Gomez M, et al. Eradication of posterior capsule opacification: documentation of a marked decrease in Nd:YAG laser posterior capsulotomy rates noted in an analysis of 5416 pseudophakic human eyes obtained postmortem. Ophthalmology. 2001;108(3):505-18.
- Nishi O, Nishi K, Osakabe Y. Effect of intraocular lenses on preventing posterior capsule opacification: design versus material. J Cataract Refract Surg. 2004;30(10):2170-6.
- Steinert RF, Puliafito CA, Kumar SR, Dudak SD, Patel S. Cystoid macular edema, retinal detachment, and glaucoma after Nd:YAG laser posterior capsulotomy. Am J Ophthalmol. 1991;112(4):373-80.
- Aslam TM, Devlin H, Dhillon B. Use of Nd:YAG laser capsulotomy. Surv Ophthalmol. 2003;48(6):594-612.
- Karahan E, Er D, Kaynak S. An overview of Nd:YAG laser capsulotomy. Med Hypothesis Discov Innov Ophthalmol. 2014;3(2):45-50.
